middle.news
AdAlta gains R&D support for China work on EW-001
8:48am on Monday 19th of October, 2026 AEDT
•
Biotechnology
Read Story
AdAlta gains R&D support for China work on EW-001
8:48am on Monday 19th of October, 2026 AEDT
Key Points
More than A$1 million additional FY26 R&D refund expected
A$0.23 million first FY26 instalment already received
Finding covers China trials, IND-enabling studies and manufacturing materials
FDA pre-IND meeting scheduled for 4 November 2026 AEST
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE